BACKGROUND & AIMS: The incidence of esophageal adenocarcinoma (EAC) in blacks and Hispanics is well-described, but racial differences in the risk of Barrett's esophagus (BE) have not been directly studied. It is important to determine whether race and ethnicity can be identified as risk factors for the development of metaplasia, neoplastic progression, or both. METHODS: We performed a single center retrospective cross-sectional analysis of all patients who underwent upper endoscopy during a 1-year period. Patients with a prior endoscopy within 5 years or known BE or EAC were excluded. Suspected cases of BE were confirmed by pathology report. RESULTS: A total of 2100 patients met inclusion criteria. Whites (37.7%), blacks (11.8%), and Hispanics (22.2%) comprised the majority. Whites had a significantly higher prevalence of BE than Hispanics (6.1% vs 1.7%, P = .0002) and blacks (6.1% vs 1.6%, P = .004). In multivariable analysis, factors associated with decreased risk of BE were black race (odds ratio [OR], 0.34; 95% confidence interval [CI], 0.12-0.97) and Hispanic ethnicity (OR, 0.38; 95% CI, 0.18-0.84). Male sex (OR, 1.86; 95% CI, 1.20-2.87), reflux symptoms (OR, 2.87; 95% CI, 1.84-4.45), hiatal hernia (OR, 3.53; 95% CI, 2.17-5.72), and older age were associated with increased risk of BE. CONCLUSIONS: Among patients who undergo upper endoscopy, blacks and Hispanics have a significantly lower prevalence of BE compared with whites. These differences in prevalence are comparable to the relative incidence rates observed with EAC, implying that progression from BE to adenocarcinoma does not vary by race/ethnicity. Reasons for lower rates of BE in Hispanics and blacks need further investigation.
BACKGROUND & AIMS: The incidence of esophageal adenocarcinoma (EAC) in blacks and Hispanics is well-described, but racial differences in the risk of Barrett's esophagus (BE) have not been directly studied. It is important to determine whether race and ethnicity can be identified as risk factors for the development of metaplasia, neoplastic progression, or both. METHODS: We performed a single center retrospective cross-sectional analysis of all patients who underwent upper endoscopy during a 1-year period. Patients with a prior endoscopy within 5 years or known BE or EAC were excluded. Suspected cases of BE were confirmed by pathology report. RESULTS: A total of 2100 patients met inclusion criteria. Whites (37.7%), blacks (11.8%), and Hispanics (22.2%) comprised the majority. Whites had a significantly higher prevalence of BE than Hispanics (6.1% vs 1.7%, P = .0002) and blacks (6.1% vs 1.6%, P = .004). In multivariable analysis, factors associated with decreased risk of BE were black race (odds ratio [OR], 0.34; 95% confidence interval [CI], 0.12-0.97) and Hispanic ethnicity (OR, 0.38; 95% CI, 0.18-0.84). Male sex (OR, 1.86; 95% CI, 1.20-2.87), reflux symptoms (OR, 2.87; 95% CI, 1.84-4.45), hiatal hernia (OR, 3.53; 95% CI, 2.17-5.72), and older age were associated with increased risk of BE. CONCLUSIONS: Among patients who undergo upper endoscopy, blacks and Hispanics have a significantly lower prevalence of BE compared with whites. These differences in prevalence are comparable to the relative incidence rates observed with EAC, implying that progression from BE to adenocarcinoma does not vary by race/ethnicity. Reasons for lower rates of BE in Hispanics and blacks need further investigation.
Authors: M X Tang; P Cross; H Andrews; D M Jacobs; S Small; K Bell; C Merchant; R Lantigua; R Costa; Y Stern; R Mayeux Journal: Neurology Date: 2001-01-09 Impact factor: 9.910
Authors: Jukka Ronkainen; Pertti Aro; Tom Storskrubb; Sven-Erik Johansson; Tore Lind; Elisabeth Bolling-Sternevald; Michael Vieth; Manfred Stolte; Nicholas J Talley; Lars Agréus Journal: Gastroenterology Date: 2005-12 Impact factor: 22.682
Authors: Brian C Jacobson; Samuel C Somers; Charles S Fuchs; Ciarán P Kelly; Carlos A Camargo Journal: N Engl J Med Date: 2006-06-01 Impact factor: 91.245
Authors: J J Vicari; R M Peek; G W Falk; J R Goldblum; K A Easley; J Schnell; G I Perez-Perez; S A Halter; T W Rice; M J Blaser; J E Richter Journal: Gastroenterology Date: 1998-07 Impact factor: 22.682
Authors: Panteleimon Kountourakis; Jaffer A Ajani; Marta Davila; Jeffrey H Lee; Manoop S Bhutani; Julie G Izzo Journal: Gastrointest Cancer Res Date: 2012-03
Authors: Stuart J Spechler; Prateek Sharma; Rhonda F Souza; John M Inadomi; Nicholas J Shaheen Journal: Gastroenterology Date: 2011-03 Impact factor: 22.682
Authors: Joe E Khoury; Sian Chisholm; M Mazen Jamal; Carlos Palacio; Sunitha Pudhota; Kenneth J Vega Journal: Dig Dis Sci Date: 2011-09-11 Impact factor: 3.199
Authors: Jennifer R Kramer; Lori A Fischbach; Peter Richardson; Abeer Alsarraj; Stephanie Fitzgerald; Yasser Shaib; Neena S Abraham; Maria Velez; Rhonda Cole; Bhupinderjit Anand; Gordana Verstovsek; Massimo Rugge; Paola Parente; David Y Graham; Hashem B El-Serag Journal: Clin Gastroenterol Hepatol Date: 2012-12-04 Impact factor: 11.382